Biotech | October 29, 2021
Merck expands capacity for Antibody Drug Conjugate (ADC), therapies
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
Acute therapies continue to report strong growth compared to chronic ones.
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
It plans to double its network to 50 centres across India in the next three years
This funding will help the start-up consolidate its position as a one-stop destination for pet parents as they holistically reimagine the entire pet care ecosystem
Moderate-to-severe plaque psoriasis affects about 35 per cent of patients. A key challenge is that many treatments stop working overtime and symptoms return
It answers the most basic questions from a patient’s perspective
The list of kids with co-morbidities eligible for vaccination would be announced by the government
Expands wound care portfolio and aims to drive greater market penetration and availability in the wound dressing category
Subscribe To Our Newsletter & Stay Updated
